Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Frank BurrellScientific Storytelling
Paul TheisenPatient Acquisition
Phase 1/2 Studies will Evaluate the Combination of Imfinzi® (Durvalumab) and Sacituzumab Govitecan in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email